{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:02:32Z","timestamp":1780538552771,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.vaccine.2015.02.025","type":"journal-article","created":{"date-parts":[[2015,2,21]],"date-time":"2015-02-21T03:19:38Z","timestamp":1424488778000},"page":"1839-1845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Immune responses following meningococcal serogroups A, C, Y and W polysaccharide vaccination in C2-deficient persons: Evidence for increased levels of serum bactericidal antibodies"],"prefix":"10.1016","volume":"33","author":[{"given":"Nicholas","family":"Brodszki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillemor","family":"Skattum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilian","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Findlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran","family":"J\u00f6nsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.02.025_bib0255","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1128\/CMR.4.3.359","article-title":"Infectious diseases associated with complement deficiencies","volume":"4","author":"Figueroa","year":"1991","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0260","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00005792-198409000-00001","article-title":"Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency","volume":"63","author":"Ross","year":"1984","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0265","doi-asserted-by":"crossref","first-page":"9347","DOI":"10.1016\/S0021-9258(19)50430-6","article-title":"Type I human complement C2 deficiency. A 28-base pair gene deletion causes skipping of exon 6 during RNA splicing","volume":"267","author":"Johnson","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0270","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000019075","article-title":"Molecular genetics of the human MHC complement gene cluster","volume":"15","author":"Yu","year":"1998","journal-title":"Exp Clin Immunogenet"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0275","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.4049\/jimmunol.151.10.5856","article-title":"Characterization of type I complement C2 deficiency MHC haplotypes strong conservation of the complotype\/HLA-B-region and absence of disease association due to linked class II genes","volume":"151","author":"Truedsson","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0280","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/rheumatology\/kem023","article-title":"Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency","volume":"46","author":"J\u00f6nsson","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0285","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.md.0000152371.22747.1e","article-title":"Hereditary C2 deficiency in Sweden: frequent occurrence of invasive infection, atherosclerosis, and rheumatic disease","volume":"84","author":"J\u00f6nsson","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0290","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.molimm.2005.06.025","article-title":"Complement deficiency and disease: an update","volume":"43","author":"Sj\u00f6holm","year":"2006","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0295","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1699-0463.1990.tb05008.x","article-title":"Inherited complement deficiency states: implications for immunity and immunological disease","volume":"98","author":"Sj\u00f6holm","year":"1990","journal-title":"APMIS: Acta Pathol Microbiol Immunol Scand"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0300","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0171-2985(98)80037-5","article-title":"Mannose-binding lectin (MBL) in health and disease","volume":"199","author":"Turner","year":"1998","journal-title":"Immunobiology"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0305","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/infdis\/157.4.697","article-title":"Analysis of C3 deposition and degradation on bacterial surfaces after opsonization","volume":"157","author":"Gordon","year":"1988","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0310","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF01893019","article-title":"The alternative pathway of complement","volume":"7","author":"Pangburn","year":"1984","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0315","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF02116280","article-title":"The role of antibody in the activation of the alternative complement pathway","volume":"6","author":"Ratnoff","year":"1983","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.1991.tb08115.x","article-title":"The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions","volume":"84","author":"Valim","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0325","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.clim.2012.06.008","article-title":"Vaccination against encapsulated bacteria in hereditary C2 deficiency results in antibody response and opsonization due to antibody-dependent complement activation","volume":"144","author":"J\u00f6nsson","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0330","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.4049\/jimmunol.143.7.2256","article-title":"Lysis of sensitized sheep erythrocytes in human sera deficient in the second component of complement","volume":"143","author":"Knutzen Steuer","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0335","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1056\/NEJM198704093161506","article-title":"Familial properdin deficiency and fatal meningococcemia correction of the bactericidal defect by vaccination","volume":"316","author":"Densen","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0340","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1046\/j.1365-2249.1998.00738.x","article-title":"Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine","volume":"114","author":"Fijen","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0345","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF01965264","article-title":"Immune response to tetravalent meningococcal vaccine: opsonic and bactericidal functions of normal and properdin deficient sera","volume":"8","author":"S\u00f6derstr\u00f6m","year":"1989","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0350","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/infdis\/168.1.227","article-title":"Vaccination and the role of capsular polysaccharide antibody in prevention of recurrent meningococcal disease in late complement component-deficient individuals","volume":"168","author":"Andreoni","year":"1993","journal-title":"J Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2015.02.025_bib0355","doi-asserted-by":"crossref","first-page":"B51","DOI":"10.1016\/j.vaccine.2009.04.063","article-title":"Global epidemiology of meningococcal disease","volume":"27","author":"Harrison","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0360","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The multilaboratory study group","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0365","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-3083.1994.tb03458.x","article-title":"The importance of G1m and 2 allotypes for the IgG2 antibody levels and avidity against pneumococcal polysaccharide type 1 within mono- and dizygotic twin-pairs","volume":"40","author":"Konradsen","year":"1994","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0370","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/intimm\/2.4.317","article-title":"Effect of Gm allotypes on IgG2 antibody responses and IgG2 concentrations in children and adults","volume":"2","author":"Sarvas","year":"1990","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0375","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1086\/514935","article-title":"Association of human Fc gamma RIIa (CD32) polymorphism with susceptibility to and severity of meningococcal disease","volume":"27","author":"Platonov","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0380","first-page":"161","article-title":"Screening for deficiencies in the classical and alternative pathways of complement by hemolysis in gel","volume":"89","author":"Truedsson","year":"1981","journal-title":"Acta Pathol Microbiol Scand [C]"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0385","first-page":"147","article-title":"Complement components in 100 newborns and their mothers determined by electroimmunoassay","volume":"91","author":"Johnson","year":"1983","journal-title":"Acta Pathol Microbiol Immunol Scand [C]"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0390","first-page":"263","article-title":"Laboratory investigation of complement proteins and complement receptors","volume":"2","author":"Cooper","year":"1988","journal-title":"Baillieres Clin Immunol Allergy"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0395","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2249.2004.02690.x","article-title":"Deficiency of the Mannan-binding lectin pathway of complement and poor outcome in cystic fibrosis: bacterial colonization may be decisive for a relationship","volume":"139","author":"Carlsson","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0400","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1515\/CCLM.1999.091","article-title":"Towards common reference intervals in clinical chemistry. An attempt at harmonization between three hospital laboratories in Skane, Sweden","volume":"37","author":"B\u00e4ck","year":"1999","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0405","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1542\/peds.37.5.715","article-title":"Serum levels of immune globulins in health and disease: a survey","volume":"37","author":"Stiehm","year":"1966","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0410","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.4049\/jimmunol.155.6.3013","article-title":"Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein","volume":"155","author":"Madsen","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0415","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1002\/art.10438","article-title":"Genetic linkage and association of Fcgamma receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus","volume":"46","author":"Edberg","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0420","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/abio.2000.4493","article-title":"Single-nucleotide polymorphism analysis by pyrosequencing","volume":"280","author":"Ahmadian","year":"2000","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0425","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1034\/j.1399-0039.2003.00048.x","article-title":"Three new alleles of IGHG2 and their prevalence in Danish Caucasians, Mozambican Blacks and Japanese","volume":"61","author":"Hougs","year":"2003","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0430","doi-asserted-by":"crossref","first-page":"722","DOI":"10.4049\/jimmunol.177.1.722","article-title":"Homozygosity for the IgG2 subclass allotype G2M(n) protects against severe infection in hereditary C2 deficiency","volume":"177","author":"J\u00f6nsson","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0435","first-page":"31","article-title":"Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications","volume":"86","author":"Hermaszewski","year":"1993","journal-title":"Q J Med"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0440","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0065-2776(01)76021-X","article-title":"Systemic lupus erythematosus, complement deficiency, and apoptosis","volume":"76","author":"Pickering","year":"2000","journal-title":"Adv Immunol"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0445","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1084\/jem.129.6.1385","article-title":"Human immunity to the meningococcus V. The effect of immunization with meningococcal group C polysaccharide on the carrier state","volume":"129","author":"Gotschlich","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0450","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.129.6.1367","article-title":"Human immunity to the meningococcus IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers","volume":"129","author":"Gotschlich","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0455","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/infdis\/121.4.372","article-title":"Cutaneous reactions and antibody response to meningococcal group C polysaccharide vaccines in man","volume":"121","author":"Artenstein","year":"1970","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0460","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM197002192820803","article-title":"Prevention of meningococcal disease by group C polysaccharide vaccine","volume":"282","author":"Artenstein","year":"1970","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0465","series-title":"Technical report series, no. 594","article-title":"Requirements for meningococcal polysaccharide vaccine","author":"WHO","year":"1976"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0470","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","article-title":"Meningococcal surrogates of protection\u2014serum bactericidal antibody activity","volume":"23","author":"Borrow","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0475","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2249.1996.d01-851.x","article-title":"Different Gm allotype amounts in human intravenous immunoglobulin (IVIG) preparations; survival of foreign Gm allotypes in immunodeficient patients","volume":"106","author":"Oxelius","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0198-8859(82)90045-3","article-title":"HLA-and Gm-linked genes affecting the degradation rate of antigens (sheep red blood cells) endocytized by macrophages","volume":"4","author":"Legrand","year":"1982","journal-title":"Hum Immunol"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0485","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000049190","article-title":"Immunoglobulin GM and KM allotypes in systemic lupus erythematosus","volume":"18","author":"Pandey","year":"2001","journal-title":"Exp Clin Immunogenet"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0490","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1182\/blood-2004-01-0346","article-title":"Human blood IgM memory B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire","volume":"104","author":"Weller","year":"2004","journal-title":"Blood"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2015.02.025_bib0495","doi-asserted-by":"crossref","first-page":"B117","DOI":"10.1016\/j.vaccine.2009.04.066","article-title":"Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease","volume":"27","author":"Granoff","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.02.025_bib0500","first-page":"485","article-title":"Opsonophagocytosis of fluorescent polystyrene beads coupled to Neisseria meningitidis serogroup A, C, Y, or W135 polysaccharide correlates with serum bactericidal activity","volume":"9","author":"Martinez","year":"2002","journal-title":"Clin Diagn Lab Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15002029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15002029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T18:32:53Z","timestamp":1691346773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15002029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":50,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0264410X15002029"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.02.025","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune responses following meningococcal serogroups A, C, Y and W polysaccharide vaccination in C2-deficient persons: Evidence for increased levels of serum bactericidal antibodies","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}